The study was funded by the National Institute of General Medical Science (grant R01GM101430) and the National Human Genome Research Institute (grant U54HG004028).
Information about Stanford’s Department of Medicine, which also supported the work, is available at http:// http://medicine.stanford.edu/.
* Bruce Goldman is a science writer for the medical school’s Office of Communication & Public Affairs. Email him at goldmanb@stanford.edu
Journal reference: Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. Nigam H. Shah , Paea LePendu , Anna Bauer-Mehren, Yohannes T. Ghebremariam, Srinivasan V. Iyer, Jake Marcus, Kevin T. Nead, John P. Cooke, Nicholas J. Leeper. Published Plos one: June 10, 2015. DOI: 10.1371/journal.pone
Watch video: Common heartburn drugs could raise risk of heart attacks